American Medical Research Inc

Mobile Anesthesiologists, based in Chicago, is a pioneering anesthesia practice that has been serving the Chicagoland area for over 25 years. They specialize in office-based and ambulatory anesthesia, setting the national standard in patient outcomes and client satisfaction. With a physician-led approach, Mobile Anesthesiologists is dedicated to bringing health equity, improved outcomes, and lowered costs to patients, doctors, and communities through their high-quality anesthesia services. Mobile Anesthesiologists values their team of anesthesiologists, CRNAs, nurses, and clinical support staff, offering predictable work schedules, flexible hours, and a focus on patient care rather than administrative politics. They provide comprehensive anesthesia services for office-based procedures, pediatric dental care, and surgery centers, ensuring quality care and an unparalleled patient experience. With a commitment to raising the standard of care in office-based and ambulatory settings, Mobile Anesthesiologists is a trusted partner for outpatient anesthesia needs.Generated from the website

Precise Bioscience, located in Dakota Dunes, SD, specializes in regenerative medicine technologies, providing innovative products such as Xcellerate, Xcell Amnio Matrix, and X-Wedge System for both in-clinic and surgical applications. The company is committed to advancing healthcare practices through unique solutions that enhance patient outcomes. As a wholly owned subsidiary of New Horizon, Precise Bioscience emphasizes research, collaboration, and innovation, partnering with various organizations to further explore the potential of regenerative therapies. Their dedication to quality and regulatory compliance underscores their mission to support healthcare providers and improve patient care. Generated from the website

CDG Therapeutics Inc. is a biotechnology company based in Chicago, specializing in the development and commercialization of proprietary peptides derived from both pathogenic and nonpathogenic bacteria and green plants. These innovative peptides are designed to selectively enter cancer cells, inducing cell cycle arrest and leading to cell death. The company's focus on harnessing the unique properties of these peptides positions it at the forefront of cancer therapy research, contributing to advancements in treatment options. Through its commitment to science and technology, CDG Therapeutics aims to make significant strides in the fight against cancer. Generated from the website